GlassScriptPhysician profile
Jered M Cook
NPI 1558619338
$14,045.14
in general payments reported to CMS, 2019-2025
38 companies · $1,329 in 2025
The $1,329 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $693 · 2020: $1,287 · 2021: $3,391 · 2022: $4,646 · 2023: $1,262 · 2024: $1,438 · 2025: $1,329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,029.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,028.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,140.77 | 2019-2024 | Avvigo Guidance System, Watchman Flx, Rotapro |
| Amgen INC. | $1,476.63 | 2020-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,363.56 | 2019-2025 | Lifevest |
| Abbott Laboratories | $990.24 | 2021-2024 | Aveir |
| Actelion Pharmaceuticals US, INC. | $622.87 | 2021-2023 | Opsumit |
| Janssen Pharmaceuticals, INC | $619.64 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $608.89 | 2020-2024 | Farxiga, Andexxa, Wainua |
| Merck Sharp & Dohme LLC | $497.61 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $436.28 | 2020-2025 | Jardiance |
| Heartflow, INC. | $392.63 | 2021-2024 | |
| Shockwave Medical, INC | $384.19 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novo Nordisk INC | $374.85 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Penumbra, INC. | $288.43 | 2021-2023 | Penumbra System |
| Medtronic, INC. | $264.40 | 2021-2023 | Onyx Frontier |
| Atricure, INC. | $242.79 | 2022-2024 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jered Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.